Fig. 1

Phenotype characteristics and outcomes. A Distribution of the two identified phenotypes, B Standardized mean difference (SMD) of all clustering variables per phenotype, illustrating how far each variable for that group is removed from the mean of the entire cohort, C Cumulative 90-day incidence of MAKE events for the two phenotypes. D Cumulative 90-day incidence of MAKE events for ilofotase alfa- and placebo-treated patients within the two phenotypes. p values were calculated by log-rank tests